PURPOSE OF REVIEW: We provide evidence for the role of de-novo development of immune responses to self-antigens in the posttransplant period and its possible induction by alloimmunity in the pathogenesis of chronic rejection following lung, heart and kidney transplantation. The present review details recent findings for the two distinct yet interdependent immune processes in the immunopathogenesis of chronic rejection. RECENT FINDINGS: The contribution of both humoral and cell-mediated alloimmune responses against mismatched donor histocompatibility antigens (HLA) in the pathogenesis of chronic rejection is well established. Recent studies have focused on development of immune responses to self-antigens during the posttransplant period and its correlation with chronic rejection. These self-antigens include myosin and vimentin in cardiac, K-alpha-1-tubulin and collagen-V in lung and angiotensin II type 1 receptor, collagen-IV and VI in kidney transplants. During the posttransplant period, the development of immune responses to self-antigens is facilitated by induction of a distinct subset of autoreactive T-helper cells referred to as Th17 cells. SUMMARY: Following organ transplantation, tissue injury and remodeling inflicted by antibodies (Abs) to HLA antigens is conducive to develop autoimmunity. Abs to HLA and self-antigens are detectable in the serum of transplant recipients who develop chronic rejection. Anti-HLA Abs are often present transiently but precede the development of Abs to self-antigens.
PURPOSE OF REVIEW: We provide evidence for the role of de-novo development of immune responses to self-antigens in the posttransplant period and its possible induction by alloimmunity in the pathogenesis of chronic rejection following lung, heart and kidney transplantation. The present review details recent findings for the two distinct yet interdependent immune processes in the immunopathogenesis of chronic rejection. RECENT FINDINGS: The contribution of both humoral and cell-mediated alloimmune responses against mismatched donor histocompatibility antigens (HLA) in the pathogenesis of chronic rejection is well established. Recent studies have focused on development of immune responses to self-antigens during the posttransplant period and its correlation with chronic rejection. These self-antigens include myosin and vimentin in cardiac, K-alpha-1-tubulin and collagen-V in lung and angiotensin II type 1 receptor, collagen-IV and VI in kidney transplants. During the posttransplant period, the development of immune responses to self-antigens is facilitated by induction of a distinct subset of autoreactive T-helper cells referred to as Th17 cells. SUMMARY: Following organ transplantation, tissue injury and remodeling inflicted by antibodies (Abs) to HLA antigens is conducive to develop autoimmunity. Abs to HLA and self-antigens are detectable in the serum of transplant recipients who develop chronic rejection. Anti-HLA Abs are often present transiently but precede the development of Abs to self-antigens.
Authors: David O Taylor; Leah B Edwards; Mark M Boucek; Elbert P Trulock; David A Waltz; Berkeley M Keck; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2006-07-10 Impact factor: 10.247
Authors: A Jaramillo; M A Smith; D Phelan; S Sundaresan; E P Trulock; J P Lynch; J D Cooper; G A Patterson; T Mohanakumar Journal: Transplantation Date: 1999-04-27 Impact factor: 4.939
Authors: Ankit Bharat; Kishore Narayanan; Tyler Street; Ryan C Fields; Nancy Steward; Aviva Aloush; Brian Meyers; Richard Schuessler; Elbert P Trulock; G Alexander Patterson; Thalachallour Mohanakumar Journal: Transplantation Date: 2007-01-27 Impact factor: 4.939
Authors: H S Leong; B M Mahesh; J R Day; J D Smith; A D McCormack; G Ghimire; T J Podor; M L Rose Journal: J Leukoc Biol Date: 2007-11-01 Impact factor: 4.962
Authors: William J Burlingham; Robert B Love; Ewa Jankowska-Gan; Lynn D Haynes; Qingyong Xu; Joseph L Bobadilla; Keith C Meyer; Mary S Hayney; Ruedi K Braun; Daniel S Greenspan; Bagavathi Gopalakrishnan; Junchao Cai; David D Brand; Shigetoshi Yoshida; Oscar W Cummings; David S Wilkes Journal: J Clin Invest Date: 2007-11 Impact factor: 14.808
Authors: Peter T Jindra; Aileen Hsueh; Longshen Hong; David Gjertson; Xiu-Da Shen; Feng Gao; Julie Dang; Paul S Mischel; William M Baldwin; Michael C Fishbein; Jerzy W Kupiec-Weglinski; Elaine F Reed Journal: J Immunol Date: 2008-02-15 Impact factor: 5.422
Authors: V Tiriveedhi; M Takenaka; S Ramachandran; A E Gelman; V Subramanian; G A Patterson; T Mohanakumar Journal: Am J Transplant Date: 2012-07-23 Impact factor: 8.086
Authors: Julong Cheng; Ali Torkamani; Rajesh K Grover; Teresa M Jones; Diana I Ruiz; Nicholas J Schork; Michael M Quigley; F Wesley Hall; Daniel R Salomon; Richard A Lerner Journal: Proc Natl Acad Sci U S A Date: 2011-03-17 Impact factor: 11.205